drugset
drugset / Trial / NCT06723080

Phase III Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis

NCT06723080 ↗

Phase 3 Recruiting 480 enrolled Jiangsu vcare pharmaceutical technology co., LTD
RandomizedParallel-groupDouble-blindTreatment

Summary

This clinical trial is a multicenter, randomized, double-blind, controlled phase III clinical study

Timeline

Start
2024-12-30
Primary completion
2027-08-30
Completion
2027-08-30

Drugs

EvaluationDrugModalityDoseRoute
Subject VC005 Unknown — —

Indications

atopic eczema